Diabetes During Pregnancy Clinical Trial
Official title:
Non-inferiority Trial Comparing Insulin Glulisine to Insulin Lispro as Part of a Basal-bolus Insulin Regimen for the Treatment of Gestational Diabetes.
We hypothesize that insulin glulisine is non-inferior to currently proven rapid-acting insulin lispro when used in a basal/bolus regimen to treat hyperglycemia in patients with gestational diabetes mellitus.
To date, only two rapid-acting insulin analogs have been shown to be safe and effective for
the treatment of diabetes during pregnancy: insulin aspart and insulin lispro.
The pharmacokinetics and pharmacodynamics of insulin glulisine are unique and insulin
glulisine may be the best rapid-acting analog for the treatment of post-prandial
hyperglycemia. We believe that insulin glulisine should be evaluated in women with
gestational diabetes for its potential efficacy.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01907516 -
Managing Diabetes in Pregnancy Using Cell Phone/Internet Technology
|
N/A |